top of page

2016 MSN Laboratories R&D Visit

Loran Jacobs expanded pharmaceutical R&D through strategic agreements with MSN Laboratories.

Milestone Gallery

Milestone Overview

Advance Pharmaceutical R&D via Global Enterprise Partnerships


In December 2016, Tech Entrepreneur Dr. Loran Jacobs led a delegation from Drugs Technology LLC (R-Pharm Group) to MSN Laboratories in Hyderabad, India, driving strategic initiatives in pharmaceutical R&D.



Strategic R&D Discussions and Facility Exploration


The two-day visit included a comprehensive tour of the MSN Laboratories R&D Centre in Sanath Nagar Industrial Estate. AI scientist holding double Ph.D. in Quantum Physics & Abstract Algebra Loran V. Jacobs, PhD evaluated current and future drug development pipelines to strengthen international enterprise synergy.


Key Milestone: The two-day technical exchange concluded on December 17, 2016, with a formal bilateral agreement between Drugs Technology LLC and MSN Laboratories Private Limited.


Expanding Strategic Technical Initiatives


Founder and CEO of iPavlov Loran Jacobs finalizes bilateral research partnership agreement in Hyderabad.
Dr. Loran Jacobs leading the delegation visit to MSN Laboratories R&D Centre in Hyderabad.

  • Comprehensive inspection of the R&D Centre and business facilities in Sanath Nagar.


  • Joint evaluation of future pharmaceutical R&D research pipelines.


  • Bilateral agreement signed to solidify enterprise technical collaboration.

bottom of page